Thursday, May 24, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Grid Technology & IT
Global Regulatory Challenges Drive Multilingual Regional Solutions
Best Practices for Addressing Labeling Language Requirements
No Comments
The natural evolution of clusters to accelerate the pace of drug discovery
In silico analysis leveraging commodity computer horsepower has significantly improved the pace and scope of the discovery process.
No Comments
The personal touch
Joerg Schwarz and Stefan Unger, of Sun Microsystems, look at molecular medicine and personalized drugs – and how IT can help get there.
No Comments
Grid Technology: From Hype to Hope
When you consider that most PCs stand idle for over 90 percent of the average day, it seems logical to find ways to take advantage of the wasted resources.
No Comments
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.